Improved prodrugs of CC-1065 analogs
Details for Australian Patent Application No. 2003218062 (hide)
International Classifications
Event Publications
31 July 2003 Complete Application Filed
Priority application(s): 10/116,053 05.04.02 US
4 December 2003 Application Open to Public Inspection
Published as AU-B-2003218062
23 August 2007 Application Accepted
Published as AU-B-2003218062
20 December 2007 Standard Patent Sealed
26 June 2008 Alteration of Name
The name of the patentee has been altered to ImmunoGen, Inc.
8 October 2009 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 15 Sep 2009. Address for service in Australia - Griffith Hack 167 Eagle Street Brisbane QLD 4000
18 February 2010 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 15 Sep 2009
18 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003218063-THERAPY FOR PSYCHOSES COMBINING AN ATYPICAL ANTIPSYCHOTIC AND AN MGLU2/3 RECEPTOR AGONIST
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser